Abstract
The 3q29 duplication syndrome is an uncommon imbalanced chromosomal disorder with highly variable manifestations, mainly characterized by a mild mental anomaly, eye abnormalities, and developmental delay. Only a few such cases have been reported with significant phenotypic heterogeneity. Here, we reported a case with familial 3q28q29 duplication that was 8.5 Mb in length, covering all fragments from previous reports. A series of genetic detection techniques, including karyotyping, chromosomal microarray, and fluorescence in situ hybridization, demonstrated that the rearrangement, in this case, was due to a three-chromosome translocation of the paternal grandmother of the fetus. Interestingly, only mild intellectual disability in the father and slightly thick nuchal translucency (NT) in the fetus were observed. The fetus was delivered at term and showed normal developmental milestones. Our study increased the understanding of this syndrome and highlighted the necessity and importance of the rational use of multiple genetic techniques in prenatal diagnosis.
Keywords: 3q29 duplication, intellectual disability, SNP array, fluorescence in situ hybridization
Introduction
With the advancements in molecular cytogenetic techniques, many novel chromosomal rearrangements and copy number variations (CNVs) have been identified and recognized as phenotype-causing [1,2]. For genome-wide assessment of CNVs, techniques like array comparative genomic hybridization (aCGH) and single nucleotide polymorphism (SNP) array are considered to be first-tier methods for the postnatal evaluation of individuals suffering from intellectual disability, developmental delay, autism spectrum disorder, and/or multiple congenital anomalies, where the prenatal evaluation and detection of structural anomalies of fetuses are performed using ultrasound [3-5]. Specifically, although microdeletions and microduplications are both induced by the same mechanism that involves non-allelic homologous recombination and region-specific low copy repeats [6], the pathogenicity of the latter is less commonly recognized or reported, probably because of ascertainment bias and milder and/or more variable phenotypes [7].
The 3q29 microduplication syndrome (MIM #611936), first described by Lisi et al. in 2008, is characterized by mild to moderate mental retardation and mild dysmorphic characteristics [8]. Clinical features of this condition include microcephaly, round face, bulbous nose, short or downward-slanting palpebral fissures, excessive hand creases, and pes planus [8]. The phenotypic heterogeneity of the 3q29 microduplication syndrome makes it difficult to define a recognizable pattern and challenges appropriate genetic counseling and procreation guidance [9]. The phenotypic spectrum of the syndrome includes ocular defects like microphthalmia/aniridia, myelomeningocele and midline cranial defects, ventricular septal defect, palatal, renal, and structural brain anomalies, and musculoskeletal anomalies (chest-wall and finger deformities) [7,8,10,11]. The psychiatric characteristics might be rare and subtle, mainly manifested as attention-deficit/hyperactivity disorders, elimination disorders, and autism spectrum disorder [12]. Additionally, this condition follows an autosomal dominant inheritance pattern, so the offspring of patients have a 50% chance of being affected.
In this study, we enrolled a case with abnormal prenatal fetal indication and performed a comprehensive clinical evaluation and genetic detection of the extended family. A novel familial 3q28q29 duplication of 8.5 Mb, covering the entire core region of 3q29 microduplication syndrome, was identified and verified. However, it only caused mild intellectual disability in an adult carrier in the family. By full informed consent, the couple decided to continue the pregnancy with this genetic rearrangement, and a clinical follow-up was conducted.
Materials and methods
This study was reviewed and authorized by the Ethics Committee of the Beijing Haidian Maternal and Child Health Hospital (Approval No. 2021-23). All participants signed the informed consent. The procedures related to human participants in the research followed the Declaration of Helsinki 1964, its subsequent amendments, and similar ethical criteria.
Subjects
A 23-year-old woman with pregnancy at the 18th gestational week was referred to our center because the fetus was diagnosed with thick nuchal translucency (NT) at 12w6d (Figure 1B). Her husband was 25 years old with seemingly normal physical signs. The pregnant woman denied that she and her husband had a family history of any genetic condition. Routine clinical tests, such as amniocentesis and prenatal genetic diagnosis, were recommended. At the 20th gestational week, amniocentesis was performed to collect fetal samples. Then, peripheral blood samples of the couple and extended family members were also collected for follow-up tests.
Figure 1.
Clinical indications in the case. A. Pedigree diagram of the family. B. The fetus (III-1) in this case showed a thickened NT at 12w6d of gestation.
Chromosomal karyotyping
Conventional G-banding technology was used for sampling the fetus and the other members to determine chromosomal abnormalities based on the AGT cytogenetics laboratory manual [13]. Standard laboratory procedures included PHA and colchicine-stimulated lymphocyte cultivation, chromosome specimen preparation, digestion via trypsin, G-band staining, and karyotype analysis, as per ISCN-2016 [14].
Chromosomal microarray analysis (CMA)
Genomic DNA extraction from fetal and paternal samples was performed with the QIAamp DNA Blood Mini Kit (Qiagen GmBH, Hilden, Germany), following the specifications of the manufacturer. Chromosomal microarray analysis (CMA) was conducted as previously described [15]. Briefly, a CytoScan 750K (Affymetrix, USA) microarray was used for testing genome-wide copy number variations (CNVs), loss of homozygosity (LOH), uniparental disomy (UPD), and mosaicism, following the specifications of the manufacturer. The Affymetrix Gene Chip Command Console software (version 4.0) and Chromosome Analysis Suite (version 2.1) (Affymetrix, USA) were used to analyze the raw data. The obtained data were entered into the UCSC database (http://genome.ucsc.edu) for analysis and compared with the DGV database (http://projects.tcag.ca/variation), using the phenotypic DECIPHER database (https://decipher.sanger.ac.uk/), PubMed database (www.ncbi.nlm.nih.gov/pubmed/), and the OMIM database (www.ncbi.nlm.nih.gov/omim) to determine the pathogenicity of specific CNVs.
Fluorescence in situ hybridization (FISH)
Fluorescence in situ hybridization (FISH) was conducted with probes of 3pter/3qter and 20pter/20qter (Cytotest, USA) on the fetal and paternal metaphase cells.
Results
Clinical manifestation
The pedigree diagram is shown in Figure 1A. The fetus (III-1) displayed a slight thickness of the NT (0.32 cm) at the end of the first trimester (12w6d); during the second and third trimesters, there was no ultrasonic anomaly. So, the couple made a fully informed choice to continue this pregnancy. A boy was delivered after 39 weeks of gestation with normal birth weight. The Apgar score was 10 at 1 min, 5 min, and 10 min. Developmental milestones were normal at 42 days, three months, six months, and one year of age, and the boy had started to walk and develop normal speech. The father scored 70 by the standard Wechsler Intelligence Scale and was recognized as having a mild intellectual disability. Other members of the family had no obvious abnormalities, and the follow-up was continued.
Genetic findings
Initially, the karyotype of the III-1 was recognized as 46,XY,?der(20) (Figure 2F) because the exact source and the rearrangement form of the der(20) chromosome were not clear. The subject II-3 carried a similar derivative chromosome 20 as the fetus (Figure 2E), while the karyotype of II-2 was normal (Figure 2D). Through extensive investigation, we found that the paternal grandmother (I-2) could be a carrier for a triple-chromosomal reciprocal translocation involving chromosomes 3, 6, and 20, denoted by 46,XX,t(3;20;6)(q28;p13;p11.2) (Figure 2B). Thus, the der(20) was inherited from I-2 to II-3 and III-1, while the other derivative chromosomes were not transmitted.
Figure 2.

The karyotypes of key members of the family. A. Subject I-1: 46, XY. B. I-2: 46, XX, t(3;20;6)(q28;p13;p11.2). C. II-1: 46, XX. D. II-2: 46, XX. E. II-3: 46, XY, der(20)t(3;20)(q28;p13). F. III-1: 46, XY, der(20)t(3;20)(q28;p13)pat. Red arrows indicate the rearranged chromosomes.
Further validation experiments were conducted with the CMA and FISH methods on subjects II-3 and III-1. CMA identified a 8.5 Mb 3q28q29 microduplication, namely arr[hg19] 3q28q29(189,336,472-197,851,444)x3, and a 342.7 Kb 20p13 microdeletion, namely arr[hg19] 20p13(61,661-404,435)x1, in both the subjects (Figure 3). The 3q28q29 duplication covered the entire region of the 3q29 duplication syndrome [8], so it was determined as “pathogenic”; the clinical significance of the 20p13 microdeletion was uncertain. To verify the CMA result, FISH was conducted with 3pter/3qter and 20pter/20qter probes on subjects II-3 and III-1. The results indicated that they both carried an extra signal of the 3q probe. Hence, it was interpreted as ish der(20)t(3;20)(3q+,20p+,20q+) (Figure 4).
Figure 3.
The diagnostic results of CMA of the subjects II-3 (A, B) and III-1 (C, D). Both individuals had a 8.5 Mb 3q28q29 microduplication, arr[hg19] 3q28q29(189,336,472-197,851,444)x3 (A, C), and a 342.7 Kb 20p13 microdeletion, arr[hg19] 20p13(61,661-404,435)x1 (B, D). Red blocks indicate the duplicated or deleted regions.
Figure 4.

FISH results of the subjects II-3 (A, B) and III-1 (C, D). (A) Probe signals of 3pter (green) and 3qter (red) indicate an extra 3qter in II-3. (B) Probe signals of 20pter (green) and 20qter (red) are normal in II-3. (C) Probe signals of 3pter (green) and 3qter (red) indicate an extra 3qter in III-1. (D) Probe signals of 20pter (green) and 20qter (red) are normal in III-1. White arrows indicate the derived chromosome carrying the extra 3qter signal.
The karyotype of each subject was conclusively found to be 46,XY,der(20)t(3;20)(q28;p13)pat for III-1, 46,XY,der(20)t(3;20)(q28;p13) for II-3, and 46,XX,t(3;20;6)(q28;p13;p11.2) for I-2 (Figure 2).
Discussion
There is a risk of misdiagnosis and missed diagnosis during prenatal genetic diagnosis, especially for cryptic and complex structural variations. Multiplatform techniques and extensive family verification should be combined for a definitive diagnosis [15].
The 3q29 duplication syndrome, which was sporadically reported initially [16,17], was not recognized as a syndrome till Lisi et al. summarized it [8]. Currently, over 35 cases with this condition have been reported [9,18]. In the largest survey cohort to date, Pollak et al. concluded that patients of 3q29dup frequently encountered problems in the first year (80.6%), such as feeding problems (55%), inability to gain weight (42%), hypotonia (39%), and respiratory distress (29%); while in early childhood, learning problems (71.0%) and seizures (25.8%) were common. Moreover, the self-reported autism spectrum disorder diagnosis rate (39%) was considerably higher than that of ordinary people, indicating the correlation of 3q29 duplication with an autism susceptibility locus [18]. Representative studies on 3q29dup and key information from such studies are summarized in Table 1. Goobie et al. proposed that the dosage effect of this segment was important for eye and cognitive development and that CNV of other segments might play a role in phenotypic changes. They proposed a set of recommended management guidelines for the disease [7]. Tassano et al. presented a case with a short duplicated segment of 448.8 kb, including the DLG1 and BDH1 genes, indicating that gain-of-dosage of these two genes was sufficient for the major clinical features related to the syndrome [19]. Ohshiro et al. demonstrated that in Drosophila, Dlg can mediate cortical protein targeting in mitotic neuroblasts differently during a common process [20]. Cotter et al. found that for Schwann cells, mammalian Dlg1 interacts with Pten to prohibit axonal stimulation for myelination [21]. The BDH1 expression level in the developing murine cortex reduces during later phases of cortex maturation [22]. In another case, Vinas-Jornet et al. detected a duplicated segment of 490 kb, containing key genes like PAK2 and FBXO45 [23]. PAK2 is closely related to cerebral cortex development and might be a core determining factor of the mental phenotype [24,25], while FBXO45 affects the development of the central and peripheral nervous systems [26].
Table 1.
The 3q29 duplication cases reported in representative literature
| Authors; year | PMID* | Size (Range) of duplication* | Number of patients | Detection methods* | Clinical manifestations* |
|---|---|---|---|---|---|
| Rooms et al.; 2006 | 16451137 | NA | 2 | MLPA | Case 1: moderate ID, behavioral problems |
| Case 2: mild mental retardation, some dysmorphic features, and neurological signs | |||||
| Rosenberg et al.; 2006 | 15980116 | 0.4 Mb (probe GS-196F4 to GS-56H22) | 1 | aCGH; FISH | Moderate ID, facial dysmorphism, ataxia |
| Lisi et al.; 2008 | 18241066 | ~1.61-1.8 Mb (Chr3: 197,145,041_198,910,079) | 5 in one family | G-banding; FISH; aCGH; SNP array | Mild to moderate ID; microcephaly |
| Goobie et al.; 2008 | 19287140 | ~1.9-2.4 Mb (range varies) | 7 from 4 families | G-banding; FISH; aCGH; SNP array; MLPA | (Variable) mainly developmental delay and significant ophthalmological anomalies |
| Ballif et al.; 2008 | 18471269 | 200 kb-2.4 Mb | 19 | aCGH | 7 patients: mild to moderate ID (common); craniosynostosis, high palate, seizures, and ventricular septal defect (each found twice) |
| Fernandez-Jaen et al.; 2014 | 24838842 | 1.607 Mb (Chr3: 195,731,956_197,339,329) | 1 | SNP array | Cerebral palsy, epilepsy, and severe intellectual disability |
| Lawrence et al.; 2017 | 28763312 | 2.94 Mb (Chr3: 195,495,220_197,851,986) | 1 | SNP array; FISH | Neonate: a lower lumbar and sacral kyphosis, myelomeningocele, nerve rootinjury, dilation of the lateral ventricles, pulmonary hypertension, hypoplastic in Right cerebellar hemisphere andoptic nerves |
| Tassano et al.; 2018 | 29501613 | ~1.89 Mb (Chr3: 195,633,970_197,532,175); 448.8 Kb (Chr3: 196,892,527_197,339,329) | 2 | aCGH | Case 1: mental and developmental delay; autism spectrum disorder; scattered nodules of heterotopic gray matter |
| Case 2: dyslalia, celiac disease, growth failure, microcephaly, mild inferior vermis hypoplasia | |||||
| Vinas-Jornet et al.; 2018 | 29882083 | 492 kb [(Chr3: 196,022,728_196,515,371)×4, mat-pat] | 2 | CMA | Case 1: mild ID, post-traumatic stress disorder, facial dysmorphology |
| Case 2: severe ID, autism spectrum disorder | |||||
| Zhang et al.; 2018 | 29467824 | 9.0 Mb (Chr3: 188,823,885-197,851,986) | 1 | G-banding; FISH; SNP array; | With a 1.7 Mb deletion at22q13.33 |
| Mental and motor developmental delay, facial dysmorphism | |||||
| Reis et al.; 2020 | 32269882 | Not mentioned | 1 | aCGH | Moderate ID, psychiatric anomaly (emotional dysregulation, incoherence) |
| Streata et al.; 2020 | 32874693 | ~1.65 Mb (Chr3: 195,979,518_197,638,922) | 1 | aCGH | Late-onset, mild ID, progressive cortical atrophy, recurrent mucosal infections with Candida albicans |
PMID, PubMed ID (https://pubmed.ncbi.nlm.nih.gov/). NA, not applicable; FISH, fluorescence in situ hybridization; aCGH, array comparative genomic hybridization; MLPA, multiplex ligation-dependent probe amplification; QF-PCR, quantitative fluorescent polymerase chain reaction; SNP, single nucleotide polymorphism; ID, intellectual disability.
This study was the first to report a hereditary imbalanced 3q28q29 duplication resulting from a complex balanced translocation of three chromosomes, and the size of the duplicated segment was 8.5 Mb, which covered all of the previously reported regions accounting for the 3q29dup syndrome. However, it only caused mild intellectual disability in an adult and no other significant abnormalities. This suggested that the phenotype is probably regulated by other factors, either genetic or environmental. Moreover, the thick NT symptom had not been discussed previously and might provide hints about this syndrome in early pregnancy. The duplicated region contains 108 genes, including those mentioned above and 14 OMIM genes (Table S1). We also considered the possible effect of 20p12 micro-deletion on the phenotype. There are 13 genes in that fragment, including one OMIM gene (RBCK1), associated with the autosomal recessive polyglucosan body myopathy 1 in the presence or absence of immunodeficiency that causes the onset of progressive proximal muscle weakness in childhood, causing difficulties in ambulation (Table S1) [27].
We recommended an MRI of the brain to be conducted at an appropriate time to ensure normal brain development and to pay attention to the development of vision and hearing. Goobie’s suggestions for long-term health monitoring and early intervention services should be referred to [7]. Additionally, we suggested that a full-length sequencing of RBCK1 should be performed to avoid missing a possible variation in another allele. The recurrent risk for further pregnancy of this couple is unpredictable, and thus, we recommended that necessary measures should be taken, including prenatal and pre-implantation diagnoses.
The limitation of this study is that the root cause of the mild intellectual disability in the adult patient could not be accurately measured, and a genotype-phenotype association could not be established in the same way. Further studies on the functions of the above genes associated with central neural development are important to understand the pathogenesis of this syndrome.
In conclusion, we reported an inherited 3q28q29 duplication arising from a complex three-chromosome translocation using a multiplatform genetic approach and reviewed the important studies on 3q29 duplication. Our study highlighted the need and importance of the rational use of multiple genetic techniques in prenatal diagnosis.
Acknowledgements
We express thanks to all participants for their support and cooperation in the research. The research was conducted during the employment of the authors in Beijing Haidian Maternal and Child Health Hospital and supported by institutional public funds.
Disclosure of conflict of interest
None.
Supporting Information
References
- 1.Li W, Xia Y, Wang C, Tang YT, Guo W, Li J, Zhao X, Sun Y, Hu J, Zhen H, Zhang X, Chen C, Shi Y, Li L, Cao H, Du H, Li J. Identifying human genome-wide CNV, LOH and UPD by targeted sequencing of selected regions. PLoS One. 2014;10:e0123081. doi: 10.1371/journal.pone.0123081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dong Z, Zhang J, Hu P, Chen H, Xu J, Tian Q, Meng L, Ye Y, Wang J, Zhang M, Li Y, Wang H, Yu S, Chen F, Xie J, Jiang H, Wang W, Choy KW, Xu Z. Low-pass whole-genome sequencing in clinical cytogenetics: a validated approach. Genet Med. 2016;18:940–948. doi: 10.1038/gim.2015.199. [DOI] [PubMed] [Google Scholar]
- 3.Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, Scherer SW, Spinner NB, Stavropoulos DJ, Tepperberg JH, Thorland EC, Vermeesch JR, Waggoner DJ, Watson MS, Martin CL, Ledbetter DH. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–764. doi: 10.1016/j.ajhg.2010.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Manning M, Hudgins L Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12:742–745. doi: 10.1097/GIM.0b013e3181f8baad. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) Genet Med. 2020;22:245–257. doi: 10.1038/s41436-019-0686-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lupski JR. Hotspots of homologous recombination in the human genome: not all homologous sequences are equal. Genome Biology. 2004;5:242. doi: 10.1186/gb-2004-5-10-242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Goobie S, Knijnenburg J, Fitzpatrick D, Sharkey FH, Lionel AC, Marshall CR, Azam T, Shago M, Chong K, Mendoza-Londono R, den Hollander NS, Ruivenkamp C, Maher E, Tanke HJ, Szuhai K, Wintle RF, Scherer SW. Molecular and clinical characterization of de novo and familial cases with microduplication 3q29: guidelines for copy number variation case reporting. Cytogenet Genome Res. 2008;123:65–78. doi: 10.1159/000184693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Lisi EC, Hamosh A, Doheny KF, Squibb E, Jackson B, Galczynski R, Thomas GH, Batista DA. 3q29 interstitial microduplication: a new syndrome in a three-generation family. Am J Med Genet A. 2008;146A:601–609. doi: 10.1002/ajmg.a.32190. [DOI] [PubMed] [Google Scholar]
- 9.Streata I, Riza AL, Sosoi S, Burada F, Ioana M. Phenotype heterogeneity in 3q29 microduplication syndrome. Curr Health Sci J. 2020;46:193–197. doi: 10.12865/CHSJ.46.02.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, McDonald M, Campbell L, Ming JE, Zackai EH, Bejjani BA, Shaffer LG. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet. 2008;1:8. doi: 10.1186/1755-8166-1-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lawrence MB, Arreola A, Cools M, Elton S, Wood KS. 3q29 chromosomal duplication in a neonate with associated myelomeningocele and midline cranial defects. Clin Dysmorphol. 2017;26:221–223. doi: 10.1097/MCD.0000000000000193. [DOI] [PubMed] [Google Scholar]
- 12.Reis F, Pereira C, Laureano M, Cartaxo T. An unusual psychiatric presentation of the 3q29 microduplication syndrome. Cureus. 2020;12:e7203. doi: 10.7759/cureus.7203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Arsham MS, Barch MJ, Lawce HJ. The AGT cytogenetics laboratory manual. New Jersey: John Wiley & Sons Inc.; 2017. [Google Scholar]
- 14.McGowan-Jordan J, Simons A, Schmid M. An international system for human cytogenomic nomenclature (2016) Basel (Switzerland): Karger; 2016. [Google Scholar]
- 15.Xing HX, Li PB, Cui LM, Jiang JY, Hu NN, Zhang XB. Whole exome sequencing facilitated the identification of a mosaic small supernumerary marker chromosome (sSMC) Biomed Res Int. 2021;2021:6258527. doi: 10.1155/2021/6258527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rooms L, Reyniers E, Wuyts W, Storm K, van Luijk R, Scheers S, Wauters J, van den Ende J, Biervliet M, Eyskens F, van Goethem G, Laridon A, Ceulemans B, Courtens W, Kooy RF. Multiplex ligation-dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clin Genet. 2006;69:58–64. doi: 10.1111/j.1399-0004.2005.00545.x. [DOI] [PubMed] [Google Scholar]
- 17.Rosenberg C, Knijnenburg J, Bakker E, Vianna-Morgante AM, Sloos W, Otto PA, Kriek M, Hansson K, Krepischi-Santos AC, Fiegler H, Carter NP, Bijlsma EK, van Haeringen A, Szuhai K, Tanke HJ. Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet. 2006;43:180–186. doi: 10.1136/jmg.2005.032268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pollak RM, Zinsmeister MC, Murphy MM, Zwick ME Emory 3q29 Project. Mulle JG. New phenotypes associated with 3q29 duplication syndrome: results from the 3q29 registry. Am J Med Genet A. 2020;182:1152–1166. doi: 10.1002/ajmg.a.61540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tassano E, Uccella S, Giacomini T, Severino M, Siri L, Gherzi M, Celle ME, Porta S, Gimelli G, Ronchetto P. 3q29 microduplication syndrome: description of two new cases and delineation of the minimal critical region. Eur J Med Genet. 2018;61:428–433. doi: 10.1016/j.ejmg.2018.02.011. [DOI] [PubMed] [Google Scholar]
- 20.Ohshiro T, Yagami T, Zhang C, Matsuzaki F. Role of cortical tumour-suppressor proteins in asymmetric division of drosophila neuroblast. Nature. 2000;408:593–596. doi: 10.1038/35046087. [DOI] [PubMed] [Google Scholar]
- 21.Cotter L, Ozcelik M, Jacob C, Pereira JA, Locher V, Baumann R, Relvas JB, Suter U, Tricaud N. Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science. 2010;328:1415–1418. doi: 10.1126/science.1187735. [DOI] [PubMed] [Google Scholar]
- 22.Semeralul MO, Boutros PC, Likhodi O, Okey AB, Van Tol HH, Wong AH. Microarray analysis of the developing cortex. J Neurobiol. 2006;66:1646–1658. doi: 10.1002/neu.20302. [DOI] [PubMed] [Google Scholar]
- 23.Vinas-Jornet M, Esteba-Castillo S, Baena N, Ribas-Vidal N, Ruiz A, Torrents-Rodas D, Gabau E, Vilella E, Martorell L, Armengol L, Novell R, Guitart M. High incidence of copy number variants in adults with intellectual disability and co-morbid psychiatric disorders. Behav Genet. 2018;48:323–336. doi: 10.1007/s10519-018-9902-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Cau J, Faure S, Vigneron S, Labbé JC, Labbe C, Morin N. Regulation of Xenopus p21-activated Kinase (X-PAK2) by Cdc42 and maturation-promoting factor controls xenopus oocyte maturation. J Biol Chem. 2000;275:2367–2375. doi: 10.1074/jbc.275.4.2367. [DOI] [PubMed] [Google Scholar]
- 25.Demyanenko GP, Halberstadt AI, Rao RS, Maness PF. CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. Neuroscience. 2010;165:107–115. doi: 10.1016/j.neuroscience.2009.09.077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Saiga T, Fukuda T, Matsumoto M, Tada H, Okano HJ, Okano H, Nakayama KI. Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development. Mol Cell Biol. 2009;29:3529–3543. doi: 10.1128/MCB.00364-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israël L, Trevejo-Nunez G, Bogunovic D, Cepika AM, MacDuff D, Chrabieh M, Hubeau M, Bajolle F, Debre M, Mazzolari E, Vairo D, Agou F, Virgin HW, Bossuyt X, Rambaud C, Facchetti F, Bonnet D, Quartier P, Fournet JC, Pascual V, Chaussabel D, Notarangelo LD, Puel A, Israël A, Casanova JL, Picard C. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012;13:1178–1186. doi: 10.1038/ni.2457. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


